Announcements Trials
Browse Landscape

Status

Completed 15Unknown 4Recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 54Observational 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 1Immunoglobulin Light-chain Amyloidosis 1Acute-Phase Reaction 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Bortezomib × Clear all
NCT06627309 2026-03-09

Rapid dFLC Response Predict CHR in AL Amyloidosis

Peking University People's Hospital

Recruiting
50 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT06284395 2024-10-02

Two Schemes Response in Multiple Myeloma

Hospital General de Mexico

Recruiting
83 enrolled
Plasma cell

Acute-Phase Reaction, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡